Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center, dicscusses how hospitals have responded to having to post standard charges of their services online by uploading their chargemasters.
Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center, dicscusses how hospitals have responded to having to post standard charges of their services online by uploading their chargemasters.
Transcript
As of January, hospitals are now required to make a list of standard charges for all of their services available online, but many hospitals have responded to this by uploading their chargemasters. How is this making it difficult for patients to interpret and understand these prices?
Chargemaster data is almost uninterpretable to the everyday American. But, it’s a first step toward price transparency that’s desperately needed right now. I think over time, technology groups and navigation apps will consolidate the data and provide it with an easy user interface so that you’ll be able to look up, when you need to deliver a baby, that Hospital A has an average markup of 2-fold Medicare allowable amount, which may be a reasonable amount given the quality of care. Markups should not be a negative term. People are happy to pay more for better quality. But, for the same quality of service, if Hospital A is offering it for a 2-fold markup and Hospital B is offering it for a 8-fold markup, if a technology company can consolidate and aggregate that data so it’s understandable to the everyday consumer shopping for care, it could be a very powerful tool in healthcare.
Some people would say consumers don’t use pricing information in healthcare and when they do, they just pick the more expensive service thinking it’s higher quality. That may be true for a small group of people who are not paying directly, but by in large, markets are driven by proxy shoppers, that’s the fraction of consumers who are shopping on price diligently. Some people at the grocery store will compare a lemon at Grocery Store A to a lemon at Grocery Store B and they are aware of an individual change in prices. People look at gas prices the same way sometimes. I like going to Place A because it’s 2 cents cheaper on the gallon. Now, I personally don’t really shop on a penny level when it comes to gas prices. But, those other proxy shoppers drive the market so that prices come down for everybody, including shoppers like me.
Health plans, employers, the out-of-network patients, these are proxy shoppers in healthcare that can have a powerful impact in healthcare even with chargemaster prices. Ultimately, I think medical centers are going to see the benefit of offering honest and fair prices. When I say honest and fair, I mean it doesn’t change 6-fold depending on who you are or where you live or who your employer is, but a standard, flat, all-encompassing price that doesn’t come with surprise bills that hit you 3, 6, and 10 months later, and the market will reward those disruptors. We’ve already seen it with bundles that are now sold on the market for services, we’ve seen it with The Surgery Center of Oklahoma, we’ve seen it with members of the Free Market Medical Association. People are hungry for honest and fair pricing.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More